問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberBO45217
Active

2024-06-01 - 2030-12-31

Phase III

Not yet recruiting6

ICD-10C34.90

Malignant neoplasm of unspecified part of unspecified bronchus or lung

ICD-10C34.91

Malignant neoplasm of unspecified part of right bronchus or lung

ICD-10C34.92

Malignant neoplasm of unspecified part of left bronchus or lung

ICD-10C7A.090

Malignant carcinoid tumor of the bronchus and lung

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9162.9

Malignant neoplasm of bronchus and lung, unspecified

  • Trial Applicant

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator JIN-YUAN SHIH Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Jih-Hsiang Lee Division of Hematology & Oncology

Co-Principal Investigator

  • 張建仁 Division of General Internal Medicine
  • 劉家榮 Division of General Internal Medicine
  • 温岳峯 Division of General Internal Medicine
  • 陳論哲 Division of General Internal Medicine
  • 柯政昌 Division of General Internal Medicine
  • 鄒秉諴 Division of General Internal Medicine
  • 林振傑 Division of General Internal Medicine
  • 于鎧綸 Division of General Internal Medicine
  • 陳詩宇 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Yung-Hung Luo Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Gee-chen Chang Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Jen-Yu Hung Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 柯皓文 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    30 participants

  • Global

    320 participants